LOF PARTNERS LLC 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 19, 2013
Insider Transaction Report
Form 4
Transactions
- Other
Series E Convertible Preferred Stock
2007-06-01+22,328→ 301,425 totalExercise: $1.37From: 2007-06-01→ Common Stock (22,328 underlying) - Other
Series E Convertible Preferred Stock
2008-06-01+24,114→ 325,539 totalExercise: $1.37From: 2008-06-01→ Common Stock (24,114 underlying) - Other
Series E Convertible Preferred Stock
2008-06-01+15,352→ 207,255 total(indirect: By Sanders Opportunity Fund, L.P.)Exercise: $1.37From: 2008-06-01→ Common Stock (15,352 underlying) - Other
Series E Convertible Preferred Stock
2007-06-01+124,720→ 1,683,725 totalExercise: $1.37From: 2007-06-01→ Common Stock (124,720 underlying) - Other
Series E Convertible Preferred Stock
2007-06-01+14,215→ 191,903 total(indirect: By Sanders Opportunity Fund, L.P.)Exercise: $137.00From: 2007-06-01→ Common Stock (14,215 underlying) - Other
Series E Convertible Preferred Stock
2008-06-01+134,698→ 1,818,423 totalExercise: $1.37From: 2008-06-01→ Common Stock (134,698 underlying) - Other
Series E Convertible Preferred Stock
2007-06-01+45,104→ 559,076 total(indirect: By Sanders Opportunity Fund (Institutional), L.P.)Exercise: $1.37From: 2007-06-01→ Common Stock (45,104 underlying) - Other
Series E Convertible Preferred Stock
2008-06-01+48,615→ 607,691 total(indirect: By Sanders Opportunity Fund (Institutional), L.P.)Exercise: $1.37From: 2008-06-01→ Common Stock (48,615 underlying)
Footnotes (5)
- [F1]These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by Signet Healthcare Partners, LLC, the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer and manager of Signet Healthcare Partners, LLC, and SMW Investments I, LLC (as assignee of Sanders Morris Harris Inc. ), the controlling member of Signet Healthcare Partners, LLC. Signet Healthcare Partners, LLC, SMW Investments I, LLC, and James C. Gale disclaim beneficial ownnership of the reported securities except to the extent of their pecuniary interest therein.
- [F2]These securities are owned directly by Life Sciences Opportunities Fund II (Institutional), L.P. and indirectly by Signet Healthcare Partners, LLC, the general partner of Life Sciences Opportunities Fund II (Institutional), L.P., James C. Gale, the chief investment officer and manager of Signet Healthcare Partners, LLC, and SMW Investments I, LLC (as assignee of Sanders Morris Harris Inc.), the controlling member of Signet Healthcare Partners, LLC. Signet Healthcare Partners, LLC, SMW Investments I, LLC, and James C. Gale disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.
- [F3]These securities are owned directly by Sanders Opportunity Fund (Institutional), L.P. and indirectly by SMW Investments I, LLC, the controlling member of SOF Management, LLC., the general partner of Sanders Opportunity Fund (Institutional), L.P. SMW Investments I, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F4]These securities are owned directly by Sanders Opportunity Fund, L.P. and indirectly by SMW Investments I, LLC, the controlling member of SOF Management, LLC., the general partner of Sanders Opportunity Fund, L.P. SMW Investments I, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
- [F5]Shares of Series E 8% Cumulative Convertible Preferred Stock issued as a stock dividend pursuant to the terms of a Securities Purchase Agreement dated as of March 8, 2006, and are convertible into shares of common stock one a one-for-one basis. The Series E Preferred Stock bear dividends for the first two years following issuance at the rate of 8% payable in additional shares of Series E Preferred Stock.